ENLV - Latest News
Enlivex Therapeutics Ltd. (ENLV), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $3.7M. Trailing twelve-month P/E ratio is 0.00. Beta to the broader market is 1.41.
The article list below shows the most recent ENLV headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ENLV Headlines
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Shares Shorted: Short Interest Down 59.8% in September
defenseworld.net - Sep 30, 2026
Enlivex Therapeutics Ltd. (NASDAQ: ENLV - Get Free Report) was the target of a significant drop in short interest in September.
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
globenewswire.com - Sep 22, 2026
Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd.
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
zacks.com - Sep 1, 2026
Enlivex Ltd. (ENLV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart.
Comparing BioStem Technologies (OTCMKTS:BSEM) and Enlivex Therapeutics (NASDAQ:ENLV)
defenseworld.net - Aug 21, 2026
BioStem Technologies (OTCMKTS:BSEM - Get Free Report) and Enlivex Therapeutics (NASDAQ: ENLV - Get Free Report) are both small-cap healthcare companie
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
globenewswire.com - Jul 30, 2026
As of July 29, 2026, trading volume on the Rain protocol reached $860MM1 622% month-over-month growth in trading volume during July 2026 vs June 2026
How News Affects ENLV Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ENLV's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ENLV news questions
- What is the latest ENLV news headline?
- The most recent ENLV headline (Sep 30, 2026) is "Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Shares Shorted: Short Interest Down 59.8% in September". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ENLV news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ENLV news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ENLV options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.